Bystrom; Styrbjorn

Patent Applications and Registrations

Patent applications and USPTO patent grants for Bystrom; Styrbjorn.The latest application filed is for "phosphate and phosphonate derivatives of 7-amino-5-thio-thiazolo[4,5-d]pyrimidines and their use in treating conditions associated with elevated levels of cx3cr1 and/or cx3cl1".

Company Profile

1.7.14

Bystrom; Styrbjorn - Taby SE
Bystrom; Styrbjorn - Solna SE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Phosphate and phosphonate derivatives of 7-amino-5-thio-thiazolo[4,5-d]pyrimidines and their use in treating conditions associated with elevated levels of CX3CR1 and/or CX3CL1 Grant 11,339,183 - Vagberg , et al. May 24, 2	2022-05-24
Phosphate And Phosphonate Derivatives Of 7-amino-5-thio-thiazolo[4,5-d]pyrimidines And Their Use In Treating Conditions Associated With Elevated Levels Of Cx3cr1 And/or Cx3cl1 App 20210340167 - V GBERG; Jan ; et al.	2021-11-04
Phosphate And Phosphonate Derivatives Of 7-amino-5-thio-thiazolo[4,5-d]pyrimidines And Their Use In Treating Conditions Associated With Elevated Levels Of Cx3cr1 And/or Cx3cl1 App 20210292349 - V GBERG; Jan ; et al.	2021-09-23
2-phenylimidazo[4,5-b]pyridin-7-amine Derivates Useful As Inhibitors Of Mammalian Tyrosine Kinase Ror1 Activity App 20210267994 - MELLSTEDT; Hakan ; et al.	2021-09-02
A Process for the Steroselective Preparation of Chiral 2-[(Hetero)Arylalkylsulfanyl]Pyrimidines and Products Obtainable Therefrom App 20210188873 - Vagberg; Jan ; et al.	2021-06-24
2-phenylimidazo[4,5-b]pyridin-7-amine derivates useful as inhibitors of mammalian tyrosine kinase ROR1 activity Grant 11,008,318 - Mellstedt , et al. May 18, 2	2021-05-18
2-phenyl-3H-imidazo[4,5-B]pyridine derivates useful as inhibitors of mammalian tyrosine kinase ROR1 activity Grant 10,550,113 - Mellstedt , et al. Fe	2020-02-04
2-phenylimidazo[4,5-b]pyridin-7-amine Derivates Useful As Inhibitors Of Mammalian Tyrosine Kinase Ror1 Activity App 20200024272 - MELLSTEDT; Hakan ; et al.	2020-01-23
2-phenyl-3h-imidazo[4,5-b]pyridine Derivates Useful As Inhibitors Of Mammalian Tyrosine Kinase Ror1 Activity App 20180002329 - MELLSTEDT; Hakan ; et al.	2018-01-04
Sulfonamide compounds Grant 9,233,946 - Bystrom , et al. January 12, 2	2016-01-12
Aqueous solution comprising 3-quinuclidinones for the treatment hyperproliferative, autoimmune and heart disease Grant 9,061,016 - Bystrom , et al. June 23, 2	2015-06-23
Sulfonamide Compounds App 20130172339 - Bystrom; Styrbjorn ; et al.	2013-07-04
Aqueous Solution Comprising 3 - Quinuclidinones For The Treatment Hyperproliferative, Autoimmune And Heart Disease App 20120289503 - Bystrom; Styrbjorn ; et al.	2012-11-15
Novel compounds App 20100022590 - Bystrom; Styrbjorn ; et al.	2010-01-28
Process to prepare (2S)-2-(dipropylamino)-6-ethoxy-2,3-dihydro-1H-indene-5- -carboxamide App 20020151750 - Chen, Jiong Jack ; et al.	2002-10-17
Novel compounds App 20020115663 - Barker, Emma ; et al.	2002-08-22
Process to prepare (2S)-2-(dipropylamino)-6-ethoxy-2,3-dihydro-1H-indene-5- -carboxamide App 20020107418 - Chen, Jiong Jack ; et al.	2002-08-08
Novel compounds App 20020061921 - Bystrom, Styrbjorn ; et al.	2002-05-23

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.